Objective: Lactoferrin is a glycoprotein released from the secondary granules of activated neutrophils in the setting of infection. The purpose of this study was to determine if amniotic-fluid (AF) lactoferrin levels are elevated in preterm labor (PTL) patients with subclinical intraamniotic infection (IAI). Lactoferrin is an iron-binding glycoprotein present in a number of body fluids including breast milk, sweat, tears, and plasma. It has also been reported to be present at low levels in AF in early pregnancy, with increasing levels in the third trimester. The source of increasing lactoferrin levels in the third trimester is thought to be decidua. z Lactoferrin is also known to be released from the secondary granules of activated neutrophils in the presence of inflammation.
Lactoferrin is an iron-binding glycoprotein present in a number of body fluids including breast milk, sweat, tears, and plasma. It has also been reported to be present at low levels in AF in early pregnancy, with increasing levels in the third trimester. The source of increasing lactoferrin levels in the third trimester is thought to be decidua. z Lactoferrin is also known to be released from the secondary granules of activated neutrophils in the presence of inflammation. A portion of the fluid was sent to the research laboratory for microbiologic evaluation. AF cultures were performed for aerobic and anaerobic bacteria, mycoplasmas, Neisseria gonorrhoeae, and Chlamydia trachomatis, as previously described. 3 The remaining fluid was immediately centrifuged at 500-800 g for 10 min and the supernatant was stored at -70C for later evaluation of lactoferrin levels.
Placentas were collected from all patients who delivered within 72 h of amniocentesis and processed as previously described. 13 Histologic chorioamnionitis was defined by the criteria of Salafia et al. 14 
RESULTS
The median lactoferrin levels in each group are shown in Figure 1 . The median level of lactoferrin was low in nonlaboring preterm patients (group 2) and significantly higher in nonlaboring patients at term (group 1) (P < 0.0001). In the preterm patients, the median lactoferrin levels in the PTL groups (groups 3 and 4) were significantly higher than in nonlaboring preterm (PTL) patients (group 2) (P 0.002).
The effect of gestational age on lactoferrin levels in nonlaboring patients is shown in Figure 2 . Lacto- increase in AF lactoferrin levels in the third trimester. These workers also measured lactoferrin in numerous fetomaternal tissues at term and found the highest levels of lactoferrin were present in decidua compared with amnion, chorion, trophoblast, umbilical cord, and fetal serum. These findings suggest a role for lactoferrin in the normal immune mechanisms of pregnancy. It is known that lactoferrin plays a protective role by interfering with the bacterial utilization of iron molecules crucial for cell growth and metabolism. 16'17 Lactoferrin also has bacteriostatic and bacteriocidal effects in a wide range of organisms, including grampositive and gram-negative bacteria, aerobes, anaerobes, and yeasts. 18 The iron-lactoferrin complex may also provide iron that is necessary for catalyzing the production of free radicals, resulting in the killing of phagocytized bacteria. 19 
